Stock fact sheet · data as of
Koninklijke Philips N.V. (PHG): fair value, margin of safety and Wheel Score
Healthcare · Medical - Devices · Netherlands · ADR · Blend
Is PHG undervalued?
PHG has a margin of safety of 34%: the stock closed at 25.00 on 16 Oct 2026 against a GLS average fair value of 37.85. 5 of the 9 valuation models that produced a number sit above the price. Our screens treat a discount this large as a strong starting point for a cash-secured put, not as a verdict - the fair value is a model output, and a wide gap can mean the models are missing something the market knows.
There is a wide gap between Lynch (9.02) and GLS Growth (79.51). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.
The nightly engine files PHG under Blend.
Nine valuation models for PHG
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 49.52 | +98% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | 17.73 | -29% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 28.44 | +14% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 9.02 | -64% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 79.51 | +218% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 50.68 | +103% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 78.78 | +215% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | 12.51 | -50% | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend |
| EPV | 14.43 | -42% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | -6.23 | -125% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 0.0000 | -100% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Koninklijke Philips N.V. scores 7 of 9 on the Piotroski F-score, the nine yes/no tests of profitability, leverage and efficiency on the latest annual accounts - a strong reading that passes the Sunday Scan's "6 or more" rule with room to spare. A GLS Moat score of 2.3/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.
Returns on capital are thin or negative - ROIC 4.7%, ROE 8.2%, ROA 3.3% - with debt at 0.74 times equity and a free-cash-flow yield of 8.7%.
The dividend yield is 3.79% at a payout ratio of 32%; for a wheel trader holding assigned shares the dividend adds to the covered-call premium, and the ex-dividend date is worth knowing before a call is sold.
Institutional ownership scores 1/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 7 / 9 | ROIC | 4.7% |
|---|---|---|---|
| GLS Moat | 2.3 / 10 | ROE | 8.2% |
| Debt / equity | 0.74 | ROA | 3.3% |
| Free-cash-flow yield | 8.7% | Payout ratio | 32% |
| Institutions | 1 / 10 | Insiders · Congress | 5 · 5 / 10 |
Wheel Score 82: Prime
With a Wheel Score of 82, Koninklijke Philips N.V. sits in the Prime band - price, quality and premium all line up for the wheel strategy. The parts: Value 25/25, Health 16/20, Moat 3/15, Premium 20/20, Stability 18/20. A high score is a ranking, not a signal: it says nothing about timing, the earnings date or your position size.
Implied volatility is 35% on the near-the-money contracts 20-60 days out - inside the 35-60% range the Wheel Score pays full marks for: enough premium to be worth selling, not so much that the risk is unpaid. Chain open interest is 11,251 contracts across all expiries - enough for the wheel at normal size.
Volume runs at 1.1M shares a day on a market cap of $24.2B, with a beta of 0.92; the Stability part of the Wheel Score gives that 18 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 25 / 25 | 34% margin of safety | |
| Health | 16 / 20 | Piotroski 7/9 | |
| Moat | 3 / 15 | moat 2.3/10 | |
| Premium | 20 / 20 | implied volatility 35% | |
| Stability | 18 / 20 | 1.1M shares/day, $24.2B cap, beta 0.92 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
The next earnings report is due on 3 Nov 2026 (before the open), 18 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Devices
The 12 companies below are the closest to Koninklijke Philips N.V. by market cap within the Medical - Devices industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies Inc. | 70.35 | 51.87 | -36% | 58Fair | $31.8B |
| DXCM DexCom, Inc. | 87.71 | 80.03 | -10% | 78Good | $33.1B |
| ZBH Zimmer Biomet Holdings, Inc. | 91.77 | 134.51 | +32% | 87Prime | $17.5B |
| PEN Penumbra, Inc. | 320.12 | 139.38 | -130% | 54Fair | $12.6B |
| SNN Smith & Nephew plc | 27.88 | 37.94 | +27% | 90Prime | $11.7B |
| EW Edwards Lifesciences Corporation | 88.10 | 39.75 | -122% | 62Fair | $50.8B |
| ALGN Align Technology, Inc. | 149.34 | 125.50 | -19% | 66Good | $10.6B |
| GMED Globus Medical, Inc. | 78.84 | 112.94 | +30% | 92Prime | $10.6B |
| BIO Bio-Rad Laboratories, Inc. | 364.82 | 246.29 | -48% | 58Fair | $9.8B |
| GKOS Glaukos Corporation | 165.60 | - | - | 45Weak | $9.8B |
| PODD Insulet Corp. | 133.93 | 153.23 | +13% | 88Prime | $9.3B |
| BSX Boston Scientific Corporation | 44.14 | 65.77 | +33% | 95Prime | $64.0B |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about PHG
Is PHG undervalued right now?
By the GLS models, yes: at 25.00 the stock is 34% below the average fair value of 37.85 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of PHG and what does it mean?
PHG scores 82 out of 100 (Prime). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.
What is the GLS fair value for PHG?
37.85 per share as of 16 Oct 2026 - the simple average of the 9 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Koninklijke Philips N.V. report earnings next?
The next earnings report is due on 3 Nov 2026 (before the open), 18 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does PHG have listed options, and how liquid are they?
Yes. The nightly snapshot found 192 listed contracts with 11,251 open interest across all expiries and implied volatility of 35% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.